Retinal Vascular Disease
The clinical research activity is centred on polypoidal choroidal vasculopathy, with attention to its impact on macular structure and visual function in adult patients.
- Polypoidal choroidal vasculopathy
- Macular disease
- Retinal vascular pathology
Interest in this area reflects a focus on ophthalmic conditions that affect central vision and the integrity of the choroidal circulation.
Vision and Visual Acuity Outcomes
Research priorities include changes in best corrected visual acuity and other measures of functional vision in patients with symptomatic retinal disease.
- Best corrected visual acuity
- Symptomatic vision loss
- Central visual function
The sponsor’s activity in this field aligns with clinical interest in preserving and assessing sight in chronic retinal disorders.
Intravitreal Ophthalmic Therapy
The funded research includes evaluation of intravitreal treatment for posterior segment eye disease, with emphasis on therapeutic response in choroidal neovascular conditions.
- Intravitreal injections
- Posterior segment eye disease
- Choroidal neovascular disease
This area highlights a therapeutic interest in locally delivered ophthalmic interventions used to manage retinal and choroidal pathology.
Anti-VEGF-Related Treatment Evaluation
Clinical investigation extends to faricimab and related anti-VEGF strategies used in retinal disease management, with attention to efficacy, safety, and durability in ocular use.
- Faricimab
- Anti-VEGF therapy
- Ocular treatment durability
The sponsor’s portfolio places emphasis on therapeutic options for chronic retinal conditions where control of vascular leakage and disease activity is clinically relevant.
Multicentre Ophthalmology Research
The research landscape includes multicentre ophthalmology work across several countries, supporting collaborative study of retinal disorders in Caucasian patient populations.
- Multicentre clinical research
- International ophthalmic collaboration
- Caucasian patient populations
Activity in this domain is concentrated on coordinated clinical investigation in eye disease across a network of research sites.
